Soon afterward, Allison returned to MD Anderson, lured by the opportunity to launch the center's $ 30 million
Moon Shots immunotherapy research program.
Not exact matches
In his day job, at the University of Texas MD Anderson Cancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the
immunotherapy division of the
Moon Shots Program, a multidisciplinary effort tackling cancer mortality.
«The microbiome appears to shape a patient's response to cancer
immunotherapy, which opens potential pathways to use it to assess a patient's fitness for
immunotherapy and to manipulate it to improve treatment,» said Wargo, who is also co-leader of the Melanoma
Moon Shot ™, part of MD Anderson's
Moon Shots Program ™ to reduce cancer deaths by accelerating development of therapies from scientific discoveries.
«Our findings point to two potential impacts from additional research — analyzing the diversity and composition of the microbiome to predict response to
immunotherapy and modulating the gut microbiome to enhance treatment,» said Wargo, senior researcher on the project and co-leader of the Melanoma
Moon Shot ™, part of MD Anderson's
Moon Shots Program ™ to reduce cancer deaths by accelerating development of therapies from scientific discoveries.